Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fetal brain monitoring: future applications.
de Vries JI. de Vries JI. Semin Fetal Neonatal Med. 2006 Dec;11(6):423-9. doi: 10.1016/j.siny.2006.07.002. Epub 2006 Sep 7. Semin Fetal Neonatal Med. 2006. PMID: 16959555 Review.
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
de Jong PG, Quenby S, Bloemenkamp KW, Braams-Lisman BA, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OW, Hoek A, Hutten BA, Jochmans K, Koks CA, Kuchenbecker WK, Mol BW, Torrance HL, Scheepers HC, Stephenson MD, Verhoeve HR, Visser J, de Vries JI, Goddijn M, Middeldorp S. de Jong PG, et al. Among authors: de bruin jp, de vries ji. Trials. 2015 May 7;16:208. doi: 10.1186/s13063-015-0719-9. Trials. 2015. PMID: 25947329 Free PMC article. Clinical Trial.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
van Hoorn ME, Hague WM, van Pampus MG, Bezemer D, de Vries JI; FRUIT Investigators. van Hoorn ME, et al. Among authors: de vries ji. Eur J Obstet Gynecol Reprod Biol. 2016 Feb;197:168-73. doi: 10.1016/j.ejogrb.2015.12.011. Epub 2015 Dec 19. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26771908 Clinical Trial.
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
Rodger MA, Gris JC, de Vries JIP, Martinelli I, Rey É, Schleussner E, Middeldorp S, Kaaja R, Langlois NJ, Ramsay T, Mallick R, Bates SM, Abheiden CNH, Perna A, Petroff D, de Jong P, van Hoorn ME, Bezemer PD, Mayhew AD; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Rodger MA, et al. Lancet. 2016 Nov 26;388(10060):2629-2641. doi: 10.1016/S0140-6736(16)31139-4. Epub 2016 Oct 6. Lancet. 2016. PMID: 27720497
140 results